Trial Profile
Clinical Trials Insight: 700033172
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2008
Price :
$35
*
At a glance
- Drugs Raseglurant (Primary) ; Esomeprazole
- Indications Anxiety; Gastro-oesophageal reflux; Migraine
- Focus Pharmacokinetics
- Sponsors Addex Therapeutics
- 10 Sep 2008 Results reported by Addex Pharmaceuticals.
- 10 Sep 2008 Status changed from planning to completed.
- 05 May 2008 New trial record.